Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
05/2004
05/13/2004US20040091873 DNA polymerases with reduced base analog detection activity
05/13/2004US20040091872 Crystal structures of MK2 and uses thereof
05/13/2004US20040091865 Human stroke gene
05/13/2004US20040091860 Rice peroxidases with various characteristics
05/13/2004US20040091854 Polypeptides derived from rna polymerases and use thereof
05/13/2004US20040091578 Treating a protein containing disulfide bonds withthioredoxin, nicotinamide adenine dinucleotide phosphate- thioredoxin reductase and NADPH or dithiothreitol reacting the protein with physiological disulfide; administering
05/13/2004US20040091575 Bringing a denatured milk protein into contact with an enzyme which exerts a deamidating effect by acting directly on an amide group of a protein without cleaving a peptide bond or crosslinking the protein
05/13/2004US20040091474 Degradation and detection of TSE infectivity
05/13/2004US20040091473 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof
05/13/2004US20040091472 Rationally designed polysaccharide lyases derived from chrondroitinase B
05/13/2004US20040091471 Synthetic; higher specific activity than native glycuronidase
05/13/2004US20040091469 Novel enzyme having beta-glucosidase activity and use thereof
05/13/2004US20040091467 Screening, antibody production
05/13/2004DE10249642A1 Feedback-resistente Homoserin-Transsuccinylasen mit modifiziertem C-Terminus Feedback-resistant homoserine transsuccinylases with modified C-terminus
05/13/2004CA2504228A1 Protozoan rhomboid proteins
05/13/2004CA2504205A1 Angiotensin-converting enzyme containing medecine
05/13/2004CA2503749A1 Method of expressing protein having unnatural amino acid integrated thereinto
05/13/2004CA2496016A1 Methods for increasing total oil levels in plants
05/12/2004EP1418434A2 Non-invasive enzyme screen for tissue remodelling-associated conditions
05/12/2004EP1418237A2 Anti-Kazlauskas lipases
05/12/2004EP1418235A2 Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies
05/12/2004EP1418231A1 Stabilised crosslinked enzyme aggregates
05/12/2004EP1418230A2 Genetically modified penicillin amidase and methods of producing it
05/12/2004EP1418229A1 Method of stabilizing alkaline phosphatase
05/12/2004EP1418180A2 Chimeric chains that code for proteins that induce effects directed against viruses
05/12/2004EP1418179A2 Compositions and methods for detecting and modulating rna activity and gene expression
05/12/2004EP1417487A2 Epitope testing using hla
05/12/2004EP1417485A2 Phenotypic effects of ubiquinone deficiencies and methods of screening thereof
05/12/2004EP1417340A2 Method for the detection of a polymorphism in cpb2
05/12/2004EP1417328A2 Invasion complex and methods of targeting
05/12/2004EP1417327A2 Multi-site mutagenesis
05/12/2004EP1417314A2 Novel amylases and uses thereof
05/12/2004EP1417313A1 Adenosylmethionine synthetase from streptomyces sp., gene sequences coding the same and method for mass production of secondary metabolites including antibiotics thereof
05/12/2004EP1417304A2 Method and composition for inhibiting heparanase activity
05/12/2004EP1417303A2 Kinase crystal structures
05/12/2004EP1417302A2 Kinase crystal structures and materials and methods for kinase activation
05/12/2004EP1417301A2 Carbohydrates and polyols for dissolving protein crystals
05/12/2004EP1417224A2 Secreted proteins
05/12/2004EP1417055A2 Use of copper chelators to inhibit the inactivation of protein c
05/12/2004EP1416973A2 Modulation of mhc class i antigen presentation
05/12/2004EP1416968A2 Uses of chemically-modified cholinesterases for detoxification of organophosphorus compounds
05/12/2004EP1416955A2 Identification of sortase gene
05/12/2004EP1416936A1 Thiopyrane-4-ones as dna protein kinase inhibitors
05/12/2004EP1416934A2 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics
05/12/2004EP1416789A1 Propagation of human hepatoblastoma cell in non-human animals
05/12/2004EP1194531B1 Cyclic peptidomimetic urokinase receptor antagonists
05/12/2004EP1147181B1 Replicative virus driven by the promoter for telomerase reverse transcriptase for use in treating cancer
05/12/2004EP1137781B1 Mutants of rna polymerases with increased stability
05/12/2004EP1109922B1 Method for the production of heterologous polypeptides in transformed yeast cells
05/12/2004EP1038007B1 Mutant bacillus licheniformis alpha-amylase
05/12/2004EP1003372A4 A nod factor binding protein from legume roots
05/12/2004EP0990026B1 High-activity phytase granulate
05/12/2004EP0971731B1 Suppression of malignancy utilizing ribonucleotide reductase r1
05/12/2004EP0940409B1 Process for the preparation of sphingolipids and sphingolipid derivatives
05/12/2004EP0914446B1 Cytochrome p450 expression in enterobacteria
05/12/2004EP0815240B1 Novel human cyclin-dependent kinase-like proteins and methods of using the same
05/12/2004CN1496412A Method for estimating danger of diabetes typ B developed in the human species of Chinese bloodline and composition
05/12/2004CN1496405A Processer for enhanced production of pantothenate
05/12/2004CN1496401A Genes encoding proteins participating in cytokinin synthesis
05/12/2004CN1496400A Methods and microorganisms for the production of 3-(2-hydroxy-3-methyl-butyrylamino)-propionic acid (HMBPA)
05/12/2004CN1496370A Isolated GUM operon from xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof
05/12/2004CN1496271A Method of treating diseases in association with decrease in expression of AOP-1 gene or AOP-1 and remedies for diseases
05/12/2004CN1495259A Production of valuable compound by using chemically defined culture medium and adopting industrial scal fermentation process
05/12/2004CN1495258A Human tissue inhibitor of metalloprotease-4
05/12/2004CN1495257A New recombinant xylanase capable of deriving self-anaerobic mycetes, its related sequence, expression vector and host
05/12/2004CN1495252A Prduction method of exoinulase
05/12/2004CN1149293C Male tissue-perferred regulatory region and method of using same
05/12/2004CN1149292C Expression system and application of nutritive methyl pichia pastoris
05/12/2004CN1149290C Novel Human Lysozyme gene, its encodling polypeptide and the method for preparing them
05/12/2004CN1149289C Promoter from ashbya gossypii
05/12/2004CN1149283C Stable transglutaminase preparations and processer for producing them
05/12/2004CN1149282C Process for increasing cellusase activity by means of waste alcohol liquid in suger fefinery
05/12/2004CN1149281C Kinase activating dependent cyclin protein kinases, and their uses
05/12/2004CN1149280C Replacement therapy for dental caries
05/11/2004US6734344 Coniothyrium minitans β-(1,3) exoglucanase gene cbeg 1
05/11/2004US6734343 Polynucleotide comprising nucleotide sequence encoding polypeptide having flavanone-7-o-glucoside-2''-o-rhamnosyl-transferase catalytic activity
05/11/2004US6734342 Theobromine synthase polypeptide of coffee plant and the gene encoding said polypeptide
05/11/2004US6734341 Synthases/polypeptides for altering concentration or morphology of glucans/polysaccharide/amylose in plants; gene expression inhibition; genetic mapping
05/11/2004US6734340 Monocotyledon plant cells and plants which synthesise modified starch
05/11/2004US6734339 Transformed plant cells and plants regenerated from these cells, which exhibit an increase or reduced activity of starch synthases; genetic engineering
05/11/2004US6734337 Activation of fatty acid oxidation and weight reduction; obtain human, administer enzyme inhibitor, monitor humans for decrease in weight and increase in fatty acid oxidation
05/11/2004US6734295 Modified CRE recombinase gene for mammals
05/11/2004US6734293 Novel extracts, proteins, and complexes that improve the polymerization activity of nucleic acid polymerases
05/11/2004US6734283 Detection, modulation, activation of conjugation involving the protein nedd8 (neural precursor cell-expressed developmentally down regulated);
05/11/2004US6734186 Phosphodiesterase 2 inhibitor
05/11/2004US6734010 Human kinases and polynucleotides encoding the same
05/11/2004US6734009 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of immunological, brain and psychological disorders
05/11/2004US6734007 Human proteases and polynucleotides encoding the same
05/11/2004US6734006 Used to regulate extracellular matrix degradation, treats chronic obstructive pulmonary disease (copd) metastasis of malignant cells, tumor angiogenesis, inflammation, atherosclerosis and neurodegenerative diseases
05/11/2004US6734005 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of psychological disorders
05/11/2004US6734004 Modified phytases
05/11/2004US6734003 Phosphodiesterase 10
05/11/2004US6734002 Nucleotide sequences coding for the chrS protein
05/11/2004US6734001 3-phosphoinositide-dependent protein kinase
05/11/2004US6733995 Cathepsin L, its prepro form and the corresponding propeptide from ciliates
05/11/2004US6733988 For suppression of cross-link formation
05/11/2004US6733981 Antibodies to interleukin-1 β converting enzyme like apoptosis protease-3 and 4
05/11/2004US6733978 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/11/2004US6733963 Methods for the identification of inhibitors of 3-isopropylmalate dehydratase as antibiotics
05/11/2004US6733776 Treating androgenic alopecia; an antisense nucleic acid molecule that hybridizes to an androgen receptor gene so as to inhibit androgen receptor expression; an expression system therefor; and an antiandrogen